Caligan Partners LP - 31 Dec 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager: Caligan Partners LP
Reporting Manager: Caligan Partners LP
Security: Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: AVTX
Shares outstanding: 17,990,469 shares
Disclosed Ownership: 881,533 shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 17:00:13 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Caligan Partners LP	4.9%	881,533	0	881,533	/s/ David Johnson	David Johnson, Managing Partner
David Johnson	4.9%	881,533	0	881,533	/s/ David Johnson	David Johnson, Managing Partner